PTEN and cancer: We examined potential associations between patient survival and the expression of phosphatase and tensin homolog (PTEN) protein, a well-established negative regulator of the PI3K-Akt pathway whose dysregulation is associated with poor prognostic cancer outcomes [10, 11].